AnnouncementsFresenius Kabi Oncology: Resignation of director
AnnouncementsFresenius Kabi Oncology: Updates on delisting of shares
AnnouncementsFresenius Kabi Oncology: Updates on delisting
No recommendations so far.What's your call on Fresenius Kabi today? Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2556.00||0.66||2939.80||1904.15||43,479.83|
Fresenius Kabi is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,095.73 crore.The company has reported a standalone sales of Rs 45.27 crore and a Net Loss of Rs 63.63 crore for the quarter ended Dec 2013.
The company management includes Rakesh Bhargava - Non Executive Chairman, Peter F Nilsson - Managing Director & CEO, Dilip G Shah - Ind. Non-Executive Director, Michael Schonhofen - Non Executive Director, Gerrit Steen - Non Executive Director, Naresh Trehan - Ind. Non-Executive Director, Rajiv Lochan Jain - Independent Director.
It is listed on the BSE with a BSE Code of 532545 and the NSE with an NSE Code of FKONCO.
Its Registered office is at B - 310, Som Datt Chambers - I,,Bhikaji Cama Place New Delhi,Delhi - 110066.
Their Registrars are M C S Ltd.